AEGR
Morgan Stanley’s Aegerion Pharmaceuticals, Inc. AEGR Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | – | Sell |
-14,836
| Closed | -$44K | – | 6663 |
|
|
2016
Q3 | $44K | Sell |
14,836
-36,665
| -71% | -$109K | ﹤0.01% | 5642 |
|
|
2016
Q2 | $77K | Sell |
51,501
-223,233
| -81% | -$334K | ﹤0.01% | 5367 |
|
|
2016
Q1 | $1.02M | Sell |
274,734
-562,453
| -67% | -$2.08M | ﹤0.01% | 3929 |
|
|
2015
Q4 | $8.46M | Sell |
837,187
-255,927
| -23% | -$2.58M | ﹤0.01% | 2142 |
|
|
2015
Q3 | $14.9M | Buy |
1,093,114
+363,111
| +50% | +$4.94M | 0.01% | 1630 |
|
|
2015
Q2 | $13.8M | Buy |
730,003
+379,967
| +109% | +$7.21M | ﹤0.01% | 1811 |
|
|
2015
Q1 | $9.16M | Sell |
350,036
-215,621
| -38% | -$5.64M | ﹤0.01% | 2138 |
|
|
2014
Q4 | $11.8M | Buy |
565,657
+58,479
| +12% | +$1.22M | ﹤0.01% | 1909 |
|
|
2014
Q3 | $16.9M | Buy |
507,178
+445,355
| +720% | +$14.9M | 0.01% | 1568 |
|
|
2014
Q2 | $1.99M | Buy |
61,823
+2,034
| +3% | +$65.3K | ﹤0.01% | 3487 |
|
|
2014
Q1 | $2.76M | Sell |
59,789
-129,129
| -68% | -$5.97M | ﹤0.01% | 3144 |
|
|
2013
Q4 | $13.4M | Buy |
188,918
+1,122
| +0.6% | +$79.6K | 0.01% | 1675 |
|
|
2013
Q3 | $16.1M | Sell |
187,796
-13,690
| -7% | -$1.17M | 0.01% | 1402 |
|
|
2013
Q2 | $12.8M | Buy |
+201,486
| New | +$12.8M | 0.01% | 1501 |
|